Veterinary Imaging Market Size, Share, and Trends 2024 to 2034

The global veterinary imaging market size was USD 1.83 billion in 2023, calculated at USD 1.96 billion in 2024 and is expected to be worth around USD 3.86 billion by 2034. The market is slated to expand at 7.02% CAGR from 2024 to 2034

  • Last Updated : September 2024
  • Report Code : 4959
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Veterinary Imaging Market 

5.1. COVID-19 Landscape: Veterinary Imaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Veterinary Imaging Market, By Product

8.1. Veterinary Imaging Market Revenue and Volume, by Product, 2024-2034

8.1.1. X-ray

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Ultrasound

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. MRI

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. CT Imaging

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. Video Endoscopy

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Veterinary Imaging Market, By Solutions

9.1. Veterinary Imaging Market Revenue and Volume, by Solutions, 2024-2034

9.1.1. Equipment

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Accessories/Consumables

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. PACS

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Veterinary Imaging Market, By Animal Type 

10.1. Veterinary Imaging Market Revenue and Volume, by Animal Type, 2024-2034

10.1.1. Small Animals

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Large Animals

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Veterinary Imaging Market, By Application

11.1. Veterinary Imaging Market Revenue and Volume, by Application, 2024-2034

11.1.1. Orthopedics And Traumatology

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Neurology

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Respiratory

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

11.1.4. Cardiology

11.1.4.1. Market Revenue and Volume Forecast (2021-2034)

11.1.5. Dental Application

11.1.5.1. Market Revenue and Volume Forecast (2021-2034)

11.1.6. Others

11.1.6.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Veterinary Imaging Market, By End-use

12.1. Veterinary Imaging Market Revenue and Volume, by End-use, 2024-2034

12.1.1. Veterinary Hospitals & Clinics

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Other

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Veterinary Imaging Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.1.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.1.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.1.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.1.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.6.5. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.7.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.1.7.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.1.7.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.7.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.2.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.2.4. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.5. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.2.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.2.7. Market Revenue and Volume Forecast, by Application (2021-2034) 

13.2.8. Market Revenue and Volume Forecast, by End-use (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.9.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.2.9.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.2.10. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.11. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.12.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.2.12.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.2.12.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.13. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.14.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.2.14.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.2.14.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.15. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.3.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.3.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.3.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.3.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.8.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.3.8.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.3.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.9. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.10.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.3.10.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.3.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.11.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.3.11.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.3.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.4.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.4.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.4.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.4.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.8.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.4.8.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.4.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.9. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.10.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.4.10.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.4.10.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.10.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.11.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.4.11.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.4.11.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.11.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.5.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.5.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.6.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.5.6.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.5.6.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.7. Market Revenue and Volume Forecast, by End-use (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.8.2. Market Revenue and Volume Forecast, by Solutions (2021-2034)

13.5.8.3. Market Revenue and Volume Forecast, by Animal Type (2021-2034)

13.5.8.4. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.8.5. Market Revenue and Volume Forecast, by End-use (2021-2034)

Chapter 14. Company Profiles

14.1. IMV Imaging

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Shenzhen Mindray Animal Medical Technology, Co., Ltd.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Canon Medical Systems Corporation

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Hallmarq Veterinary Imaging

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. FUJIFOLD Holdings America Corporation

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Midmark Corporation

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. GE Healthcare

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Mars, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. ESAOTE SPA

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. IDEXX Laboratories

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client